Artal Group as of March 31, 2023
Portfolio Holdings for Artal Group
Artal Group holds 118 positions in its portfolio as reported in the March 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Lexicon Pharmaceuticals Com New (LXRX) | 13.0 | $218M | 90M | 2.43 | |
Beigene Sponsored Adr (BGNE) | 6.4 | $108M | 501k | 215.53 | |
Apellis Pharmaceuticals (APLS) | 4.8 | $80M | 1.2M | 65.96 | |
Scholar Rock Hldg Corp (SRRK) | 4.3 | $72M | 9.0M | 8.00 | |
Morphic Hldg (MORF) | 4.1 | $68M | 1.8M | 37.64 | |
Ww Intl (WW) | 3.6 | $61M | 15M | 4.12 | |
Mirati Therapeutics | 3.4 | $57M | 1.5M | 37.18 | |
Kymera Therapeutics (KYMR) | 3.2 | $54M | 1.8M | 29.63 | |
Cytokinetics Com New (CYTK) | 2.9 | $48M | 1.4M | 35.19 | |
Springworks Therapeutics (SWTX) | 2.8 | $47M | 1.8M | 25.74 | |
Cerevel Therapeutics Hldng I (CERE) | 2.8 | $47M | 1.9M | 24.39 | |
Revolution Medicines (RVMD) | 2.7 | $45M | 2.1M | 21.66 | |
Amicus Therapeutics (FOLD) | 2.3 | $39M | 3.5M | 11.09 | |
Igm Biosciences (IGMS) | 2.0 | $35M | 2.5M | 13.74 | |
Krystal Biotech (KRYS) | 2.0 | $33M | 412k | 80.06 | |
Sage Therapeutics (SAGE) | 1.9 | $32M | 750k | 41.96 | |
Relay Therapeutics (RLAY) | 1.6 | $28M | 1.7M | 16.47 | |
Sea Sponsored Ads (SE) | 1.6 | $26M | 303k | 86.55 | |
Agenus Com New | 1.4 | $24M | 16M | 1.52 | |
Allovir (ALVR) | 1.3 | $22M | 5.6M | 3.94 | |
Vigil Neuroscience (VIGL) | 1.3 | $22M | 2.2M | 9.79 | |
Kura Oncology (KURA) | 1.2 | $21M | 1.7M | 12.23 | |
Denali Therapeutics (DNLI) | 1.1 | $19M | 803k | 23.04 | |
Schrodinger (SDGR) | 1.1 | $18M | 700k | 26.33 | |
Seer Com Cl A (SEER) | 1.1 | $18M | 4.8M | 3.86 | |
Ventyx Biosciences (VTYX) | 1.1 | $18M | 536k | 33.50 | |
Omega Therapeutics (OMGA) | 0.9 | $15M | 2.5M | 6.03 | |
Vor Biopharma (VOR) | 0.9 | $15M | 2.8M | 5.38 | |
Fate Therapeutics (FATE) | 0.9 | $15M | 2.6M | 5.70 | |
Erasca (ERAS) | 0.8 | $14M | 4.7M | 3.01 | |
Prometheus Biosciences | 0.8 | $13M | 122k | 107.32 | |
Wave Life Sciences SHS (WVE) | 0.8 | $13M | 3.0M | 4.33 | |
Miragen Therapeutics (VRDN) | 0.8 | $13M | 505k | 25.44 | |
Generation Bio (GBIO) | 0.7 | $12M | 2.8M | 4.30 | |
Geron Corporation (GERN) | 0.7 | $12M | 5.6M | 2.17 | |
Travere Therapeutics (TVTX) | 0.7 | $12M | 512k | 22.49 | |
Natera (NTRA) | 0.7 | $11M | 200k | 55.52 | |
Aurinia Pharmaceuticals (AUPH) | 0.7 | $11M | 1.0M | 10.96 | |
Glycomimetics (GLYC) | 0.6 | $11M | 8.6M | 1.26 | |
Foghorn Therapeutics (FHTX) | 0.6 | $11M | 1.7M | 6.20 | |
Intellia Therapeutics (NTLA) | 0.6 | $10M | 276k | 37.27 | |
Alpine Immune Sciences | 0.5 | $9.2M | 1.2M | 7.72 | |
Aravive | 0.5 | $9.1M | 4.6M | 2.00 | |
Mersana Therapeutics (MRSN) | 0.5 | $9.1M | 2.2M | 4.11 | |
Replimune Group (REPL) | 0.5 | $8.8M | 500k | 17.66 | |
Bridgebio Pharma (BBIO) | 0.5 | $8.3M | 500k | 16.58 | |
Avidity Biosciences Ord (RNA) | 0.5 | $7.9M | 512k | 15.35 | |
Tg Therapeutics (TGTX) | 0.5 | $7.7M | 511k | 15.04 | |
2seventy Bio Common Stock (TSVT) | 0.5 | $7.7M | 750k | 10.20 | |
89bio (ETNB) | 0.5 | $7.6M | 500k | 15.23 | |
Fusion Pharmaceuticals | 0.4 | $7.4M | 2.0M | 3.77 | |
Repare Therapeutics Ord (RPTX) | 0.4 | $6.9M | 700k | 9.84 | |
Selecta Biosciences | 0.4 | $6.8M | 4.9M | 1.39 | |
Pliant Therapeutics (PLRX) | 0.4 | $6.8M | 255k | 26.60 | |
Ovid Therapeutics (OVID) | 0.4 | $6.5M | 2.5M | 2.58 | |
Ambrx Biopharma Sponsored Ads | 0.4 | $6.3M | 702k | 8.92 | |
Dyne Therapeutics (DYN) | 0.4 | $6.1M | 533k | 11.52 | |
Chinook Therapeutics | 0.4 | $6.0M | 259k | 23.15 | |
Iteos Therapeutics (ITOS) | 0.3 | $5.4M | 400k | 13.61 | |
Ikena Oncology (IKNA) | 0.3 | $5.3M | 1.5M | 3.45 | |
Ke Hldgs Sponsored Ads (BEKE) | 0.3 | $5.2M | 275k | 18.84 | |
Viking Therapeutics (VKTX) | 0.3 | $5.0M | 300k | 16.65 | |
Roivant Sciences SHS (ROIV) | 0.3 | $4.4M | 600k | 7.38 | |
Verve Therapeutics (VERV) | 0.3 | $4.3M | 300k | 14.42 | |
Solid Biosciences Com New (SLDB) | 0.3 | $4.3M | 909k | 4.74 | |
Syros Pharmaceuticals Com New (SYRS) | 0.2 | $3.9M | 1.5M | 2.67 | |
Annexon (ANNX) | 0.2 | $3.9M | 1.0M | 3.85 | |
Portage Fintech Acquisitn Class A Ord Shs (PFTA) | 0.2 | $3.9M | 380k | 10.24 | |
Gossamer Bio (GOSS) | 0.2 | $3.8M | 3.0M | 1.26 | |
Nanobiotix Sponsored Ads (NBTX) | 0.2 | $3.5M | 1.0M | 3.52 | |
Silence Therapeutics Ads (SLN) | 0.2 | $3.1M | 505k | 6.20 | |
Black Diamond Therapeutics (BDTX) | 0.2 | $3.1M | 1.6M | 1.89 | |
BioMarin Pharmaceutical (BMRN) | 0.2 | $3.1M | 32k | 97.23 | |
I Mab Sponsored Ads (IMAB) | 0.2 | $2.9M | 850k | 3.46 | |
Taiwan Semiconductor Mfg Sponsored Ads (TSM) | 0.2 | $2.8M | 30k | 93.03 | |
Cullinan Oncology (CGEM) | 0.2 | $2.6M | 250k | 10.23 | |
Alx Oncology Hldgs (ALXO) | 0.1 | $2.3M | 500k | 4.52 | |
Kronos Bio (KRON) | 0.1 | $2.3M | 1.5M | 1.46 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.1 | $2.2M | 2.3M | 0.96 | |
Stoke Therapeutics (STOK) | 0.1 | $2.1M | 250k | 8.33 | |
Immunic (IMUX) | 0.1 | $1.9M | 1.3M | 1.49 | |
Structure Therapeutics Sponsored Ads (GPCR) | 0.1 | $1.8M | 75k | 23.79 | |
Talaris Therapeutics | 0.1 | $1.7M | 914k | 1.88 | |
23andme Holding Class A Com (ME) | 0.1 | $1.5M | 661k | 2.28 | |
Adagene Ads (ADAG) | 0.1 | $1.5M | 1.0M | 1.45 | |
Xilio Therapeutics (XLO) | 0.1 | $1.4M | 450k | 3.17 | |
Hookipa Pharma Inc equity | 0.1 | $1.4M | 1.8M | 0.74 | |
Leap Therapeutics | 0.1 | $1.4M | 4.0M | 0.34 | |
Sana Biotechnology (SANA) | 0.1 | $1.3M | 400k | 3.27 | |
Cyclerion Therapeutics | 0.1 | $1.2M | 2.8M | 0.43 | |
Ironwood Pharmaceuticals Com Cl A (IRWD) | 0.1 | $1.2M | 111k | 10.52 | |
Taysha Gene Therapies Com Shs (TSHA) | 0.1 | $1.1M | 1.4M | 0.80 | |
Tcr2 Therapeutics Inc cs | 0.1 | $1.1M | 750k | 1.50 | |
Sqz Biotech (SQZB) | 0.1 | $900k | 1.6M | 0.56 | |
Kinnate Biopharma | 0.0 | $781k | 125k | 6.25 | |
Curis Com New | 0.0 | $775k | 1.3M | 0.60 | |
Harpoon Therapeutics | 0.0 | $744k | 1.0M | 0.74 | |
United Therapeutics Corporation (UTHR) | 0.0 | $735k | 3.3k | 224.02 | |
Arrowhead Pharmaceuticals (ARWR) | 0.0 | $665k | 26k | 25.41 | |
BioCryst Pharmaceuticals (BCRX) | 0.0 | $566k | 68k | 8.33 | |
Caribou Biosciences (CRBU) | 0.0 | $559k | 105k | 5.31 | |
Mink Therapeutics (INKT) | 0.0 | $549k | 290k | 1.90 | |
Metacrine Ord | 0.0 | $528k | 925k | 0.57 | |
Arvinas Ord (ARVN) | 0.0 | $495k | 18k | 27.34 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $455k | 500k | 0.91 | |
Hippo Hldgs Com New (HIPO) | 0.0 | $390k | 24k | 16.25 | |
Beam Therapeutics (BEAM) | 0.0 | $336k | 11k | 30.61 | |
Lava Therapeutics Nv SHS (LVTX) | 0.0 | $332k | 200k | 1.66 | |
Karuna Therapeutics Ord | 0.0 | $317k | 1.7k | 181.45 | |
Bank of America Corporation (BAC) | 0.0 | $229k | 8.0k | 28.62 | |
American Intl Group Com New (AIG) | 0.0 | $201k | 4.0k | 50.25 | |
Citizens Financial (CFG) | 0.0 | $152k | 5.0k | 30.40 | |
Prothena Corp SHS (PRTA) | 0.0 | $133k | 2.7k | 48.43 | |
Dice Therapeutics | 0.0 | $124k | 4.3k | 28.72 | |
Kineta | 0.0 | $103k | 31k | 3.32 | |
Senti Biosciences Ord (SNTI) | 0.0 | $66k | 56k | 1.19 | |
Rubius Therapeutics | 0.0 | $44k | 2.0M | 0.02 | |
Contrafect Corp Com New (CFRXQ) | 0.0 | $34k | 19k | 1.81 |